AzTrials
AzTrials

Mental Health Wellness 1OppNCT05211713

Opp - a Universal Mental Health Promoting Mobile Application for Adolescents

A study testing Opp in people with Mental Health Wellness 1, run by University of Tromso at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the project is firstly, to develop an app-based mental health intervention for adolescents. Secondly, to evaluate the effect of this app. The overarching goal is to offer a low-threshold intervention, called Opp, that is easily accessible and free to use for all adolescents in Norway. Read more about this study

Who is it for?
Ages 13 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Mental Health Wellness 1
What is being tested?
Opp
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
399 participants
Where
1 siteNorway
Study dates
1 Aug 2022to 15 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Adolescents under 16 years whose guardians have given consent

Who cannot join

  • severe developmental or cognitive challenges

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • UiT The Arctic University of Norway

    Tromsø

Other trials in Norway

About this study

Official title: Opp: The Development and Evaluation of a Mental Health App for Adolescents

The aim of the project is firstly, to develop an app-based mental health intervention for adolescents. Secondly, to evaluate the effect of this app. The overarching goal is to offer a low-threshold intervention, called Opp, that is easily accessible and free to use for all adolescents in Norway.

Read the detailed description

The intervention "Opp" will be delivered through a mobile application. The overall goals of Opp are to 1) increase well-being and mental well-being, 2) increase knowledge about mental health, 3) increase coping skills to deal with stress, 4) increase help-seeking behavior, 5) increase self-esteem, 6) increase sleep quality and 7) reduce mental health problems.

To evaluate the mobile application two studies will be conducted: A user survey and an effectiveness study with a follow-up examination after about six weeks. The effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group.

Being tested
Opp
Keywords
Mental health promotion, Coping, Adolescents, Mobile application

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OppDevice

    Opp is a universal mental health promoting mobile application for adolescents aged 13-25 years.

Study groups in NCT05211713
Study groupRoleWhat they receive
Intervention group receiving OppExperimentalThe effectiveness study will be conducted as a randomized controlled trial with an intervention group and a waiting-list control group. Data will be collected at baseline (T1, pre intervention) and after about six weeks of intervention (T2, post intervention).
Receives: Device: Opp
Control groupNo interventionThe waiting list control group will receive the intervention after study completion.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in WHO-5 (WHO-Five Well-being Index)

    WHO-5 (WHO, 1998): A five item self-report questionnaire assessing well-being on a six point scale.

    Measured: Change from baseline to six weeks after intervention.

  2. Change in SDQ (Strengths and Difficulties Questionnaire)

    SDQ (Goodman, 1997): A 25 item self-report assessing mental health and psychosocial functioning in 11-17 years old adolescents on a three point scale.

    Measured: Change from baseline to six weeks after intervention.

Secondary outcomes (4)
  1. General Self-efficacy scale (GSE)

    Resilience will be measured with the Norwegian version of the GSE (Røysamb, 1997; Schwarzer et al., 1995) which consists of 10 questions measured on a four-point scale.

    Measured: Change from baseline to six weeks after intervention.

  2. Help-seeking behavior

    Two self-report items measuring if they sought help and who they sought help from.

    Measured: Change from baseline to six weeks after intervention.

  3. Self-liking and Competence Scale

    Self-liking and Competence Scale (Silvera, Neilands, \& Perry, 2001; Tafarodi \& Swann, 2001): A 20 item self-report assessing self-liking and self-competence.

    Measured: Change from baseline to six weeks after intervention.

  4. Sleeping quality

    Sleeping quality will be measured with six questions from the Bergen Child Study (Hysing, Harvey, Stormark, Pallesen, \& Sivertsen, 2018).

    Measured: Change from baseline to six weeks after intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2022
  2. Study start1 Aug 2022
  3. Primary completion15 Nov 2023
  4. Study completion15 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Intervention and control group
Masking
None (open label)
Enrolment
399 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05211713
Sponsor's protocol ID
279207
Acronym
Opp
Status last verified
May 2026
First submitted
15 Dec 2021
Last updated
11 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hogsdal H, Kaiser S, Mabille G, Martinussen M, Jakobsen R, Kyrrestad H. The effect of a universal mobile application on adolescents' mental health and well-being. Internet Interv. 2025 Feb 18;40:100814. doi: 10.1016/j.invent.2025.100814. eCollection 2025 Jun.

    PubMed 40123821
  • Kaiser S, Rye M, Jakobsen R, Martinussen M, Hogsdal H, Kyrrestad H. A Universal Mental Health-Promoting Mobile App for Adolescents: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2023 Jan 11;12:e42119. doi: 10.2196/42119.

    PubMed 36630167

Questions about this trial

What is this clinical trial studying?

A study testing Opp in people with Mental Health Wellness 1, run by University of Tromso at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in WHO-5 (WHO-Five Well-being Index) (time frame: Change from baseline to six weeks after intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05211713, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in